Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $18.27 billion. The enterprise value is $17.73 billion.
| Market Cap | 18.27B |
| Enterprise Value | 17.73B |
Important Dates
The last earnings date was Wednesday, October 21, 2026, after market close.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 27.97 million shares outstanding. The number of shares has decreased by -5.07% in one year.
| Current Share Class | 27.97M |
| Shares Outstanding | 27.97M |
| Shares Change (YoY) | -5.07% |
| Shares Change (QoQ) | -0.64% |
| Owned by Insiders (%) | 18.66% |
| Owned by Institutions (%) | 87.87% |
| Float | 22.73M |
Valuation Ratios
The trailing PE ratio is 36.22 and the forward PE ratio is 33.99. MEDP's PEG ratio is 2.38.
| PE Ratio | 36.22 |
| Forward PE | 33.99 |
| PS Ratio | 6.44 |
| Forward PS | 6.18 |
| PB Ratio | 31.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.36 |
| P/OCF Ratio | 25.27 |
| PEG Ratio | 2.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.95, with an EV/FCF ratio of 26.56.
| EV / Earnings | 34.25 |
| EV / Sales | 6.25 |
| EV / EBITDA | 27.95 |
| EV / EBIT | 29.21 |
| EV / FCF | 26.56 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.29.
| Current Ratio | 0.83 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 117.88% and return on invested capital (ROIC) is 793.61%.
| Return on Equity (ROE) | 117.88% |
| Return on Assets (ROA) | 18.71% |
| Return on Invested Capital (ROIC) | 793.61% |
| Return on Capital Employed (ROCE) | 75.28% |
| Weighted Average Cost of Capital (WACC) | 10.25% |
| Revenue Per Employee | $430,058 |
| Profits Per Employee | $78,458 |
| Employee Count | 6,600 |
| Asset Turnover | 1.40 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $109.17 million in taxes.
| Income Tax | 109.17M |
| Effective Tax Rate | 17.41% |
Stock Price Statistics
The stock price has increased by +9.07% in the last 52 weeks. The beta is 1.11, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +9.07% |
| 50-Day Moving Average | 622.54 |
| 200-Day Moving Average | 530.37 |
| Relative Strength Index (RSI) | 53.46 |
| Average Volume (20 Days) | 336,146 |
Short Selling Information
The latest short interest is 1.61 million, so 5.76% of the outstanding shares have been sold short.
| Short Interest | 1.61M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 5.76% |
| Short % of Float | 7.09% |
| Short Ratio (days to cover) | 6.09 |
Income Statement
In the last 12 months, MEDP had revenue of $2.84 billion and earned $517.83 million in profits. Earnings per share was $18.03.
| Revenue | 2.84B |
| Gross Profit | 2.05B |
| Operating Income | 607.14M |
| Pretax Income | 626.99M |
| Net Income | 517.83M |
| EBITDA | 634.46M |
| EBIT | 607.14M |
| Earnings Per Share (EPS) | $18.03 |
Balance Sheet
The company has $705.32 million in cash and $171.46 million in debt, with a net cash position of $533.86 million or $19.09 per share.
| Cash & Cash Equivalents | 705.32M |
| Total Debt | 171.46M |
| Net Cash | 533.86M |
| Net Cash Per Share | $19.09 |
| Equity (Book Value) | 584.94M |
| Book Value Per Share | 20.92 |
| Working Capital | -251.10M |
Cash Flow
In the last 12 months, operating cash flow was $723.05 million and capital expenditures -$55.42 million, giving a free cash flow of $667.63 million.
| Operating Cash Flow | 723.05M |
| Capital Expenditures | -55.42M |
| Depreciation & Amortization | 27.33M |
| Net Borrowing | n/a |
| Free Cash Flow | 667.63M |
| FCF Per Share | $23.87 |
Margins
Gross margin is 72.24%, with operating and profit margins of 21.39% and 18.24%.
| Gross Margin | 72.24% |
| Operating Margin | 21.39% |
| Pretax Margin | 22.09% |
| Profit Margin | 18.24% |
| EBITDA Margin | 22.35% |
| EBIT Margin | 21.39% |
| FCF Margin | 23.52% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 5.07% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.76% |
| FCF Yield | 3.65% |
Analyst Forecast
The average price target for MEDP is $651.31, which is -0.28% lower than the current price. The consensus rating is "Hold".
| Price Target | $651.31 |
| Price Target Difference | -0.28% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 9.02% |
| EPS Growth Forecast (3Y) | 12.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 7 and a Piotroski F-Score of 7.
| Altman Z-Score | 7 |
| Piotroski F-Score | 7 |